News | News By Subject | News by Disease News By Date | Search News

Investor News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Under Immense Pressure, Amgen (AMGN) Outlines Strategy     10/29/2014
Cowen: Amgen (AMGN)’s Plans Are “Music To Our Ears"     10/29/2014
Ampio Pharmaceuticals, Inc. (AMPE) Could Have A Blockbuster Fourth Quarter, Says Citi     10/29/2014
Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO     10/29/2014
Amgen (AMGN) Tells Analysts It Will Improve Margins 15% By Axing 4,000 Jobs     10/28/2014
Merck & Co. (MRK) Execs “Downplaying” Gilead Sciences, Inc. (GILD)'s Harvoni Competitor, Says Analyst     10/28/2014
Citi: Sarepta Therapeutics (SRPT) Will See Competition, Concern Over FDA Delay     10/27/2014
Pfizer (PFE)'s $11 Billion Buyback Dims Prospects Of AstraZeneca PLC (AZN) Bid     10/27/2014
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited     10/24/2014
Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc. (ALXN), Says Analyst     10/24/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen     10/24/2014
Celgene (CELG) Beats The Street Again On Earnings And Analysts Couldn’t Be Happier     10/23/2014
Hold Your Horses On Splicing Amgen (AMGN), Say Citi Analysts     10/22/2014
Celgene (CELG)’s New Crohn’s Disease Drug Impressing Analysts     10/21/2014
ISI Group: AbbVie (ABBV)’s Dividend, Repurchasing Attempt Could Mean More Debt     10/21/2014

Featured Stories
Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC     10/20/2014
Full Blown Ebola Epidemic Unlikely In U.S., Says Specialist     10/20/2014
Current Climate The Best For Biotech IPOs In Decades, Says VC     10/20/2014
Walking Dead: Biotech "Zombie" Companies And Why They Are Failing     10/15/2014
BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech     10/10/2014
Cross-Over Investing All The Rage, Say VCs On Panel     10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO     10/8/2014
Venture Capital Pours Into Biotech For Biggest Quarter Since 2012: Report     10/3/2014
Biotech Boom On Third Coast Proves Everything's Bigger In Texas     10/3/2014
What Happened At BioPharm America 2014?     9/24/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential     8/26/2014
Big Investors Ask Drugmakers And Biotechs To Support Biosimilars     8/12/2014
Small But Tenacious: Two Of San Diego's Emerging Biotechs Sophiris Bio Inc. (SPHS) And Lpath, Inc. (LPTN)     7/3/2014
What Biotech Experts Will Be Chirping About at JP Morgan This Week     1/13/2014
Analyst Uncovers Why Investors Should Pay Attention To Cytori Therapeutics, Inc. (CYTX)     11/22/2013
Roche Holdings, Inc. Announces Debt Tender Offer     10/30/2014
Ambit Biosciences Announces Expiration Of Hart-Scott-Rodino Waiting Period     10/30/2014
Vanda Pharmaceuticals, Inc. (VNDA) Proposes Public Offering Of Common Stock     10/29/2014
AtheroNova Inc. (AHRO.OB) Prices Public Offering Of Common Stock And Warrants     10/29/2014
Regulus Therapeutics, Inc. (RGLS) Announces Pricing Of Public Offering Of Common Stock     10/29/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme     10/29/2014
Synergy Pharmaceuticals Announces Pricing Of Private Offering Of $175 Million Of 7.50% Convertible Senior Notes     10/29/2014
NeuroVive Pharmaceutical AB: Annual General Meeting 2015 And Information About Members Appointed To The Nomination Committee     10/29/2014
Synergy Pharmaceuticals Announces Private Offering Of Convertible Senior Notes     10/29/2014
Corbus Pharmaceuticals, Inc. Commences Trading On OTCQB Under Ticker Symbol CRBP     10/29/2014
Foamix Pharmaceuticals, Ltd. (FOMX) To Host Key Opinion Leader Meeting And Webcast On November 4th In New York City     10/29/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Entry Into $20 Million "At-The-Market" Equity Distribution Agreement With Canaccord Genuity Inc.     10/28/2014
Regulus Therapeutics, Inc. (RGLS) Announces Commencement Of Public Offering Of Common Stock     10/28/2014
Vitae Pharmaceuticals, Inc. (VTAE) Announces Exercise Of Underwriters' Option To Purchase Additional Shares Of Initial Public Offering     10/28/2014
Celator Pharmaceuticals, Inc. Announces Completion Of Its Public Offering And The Exercise In Full Of Option To Purchase Additional Units Of Common Stock And Warrants To Purchase Common Stock     10/28/2014

More News
No News Posted on that date

Career Tips
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/27/2014
Get The Inside Track: Hiring Tips From An Eli Lilly (LLY) HR Exec     10/23/2014
5 Bad Interview Answers To Avoid     10/23/2014
What Separates Good Resumes From Bad Resumes?     10/23/2014
6 Out-Of-The-Box Job Search Ideas That Worked     10/23/2014
Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond     10/17/2014
Biotech’s Biggest Hirers Of The Last 5 Years     10/13/2014
Get A Biotech Job By Thinking Like A Hiring Manager     10/9/2014
7 Deadly Interview Sins     10/9/2014
3 Ways To Uncover A Hidden Job     10/9/2014
3 Crucial Areas To Ask About During The Interview     10/9/2014
How To Land The Perfect R&D Job: A Q&A With Luminex Corporation (LMNX)     9/26/2014
The One Job Search Technique That Eliminates Your Competition     9/25/2014
The Secret To Being The Only Person Applying For the Job     9/25/2014
5 Golden Rules For Negotiating Salary     9/25/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->